Blood-based monitoring identifies acquired and targetable driver HER2 mutations in endocrine-resistant metastatic breast cancer. External Web Site Icon Medford Arielle J et al. NPJ precision oncology 2019 18

Specific PHGKB|Cancer|PHGKB

Cancer

- Cancer PHGKB -

What's New

Last Posted: Aug 17, 2019

---

• A 23 gene–based molecular prognostic score precisely predicts overall survival of breast cancer patients  
  H Shimizu et al, E Biomedicine, August 2019
• Blood-based monitoring identifies acquired and targetable driver HER2 mutations in endocrine-resistant metastatic breast cancer.  
  Medford Arielle J et al. NPJ precision oncology 2019 18
• Evaluation of POLE and POLD1 Mutations as Biomarkers for Immunotherapy Outcomes Across Multiple Cancer Types.  
  Wang Feng et al. JAMA oncology 2019 Aug
• Rates of Actionable Genetic Findings in Individuals with Colorectal Cancer or Polyps Ascertained from a Community Medical Setting  
  AS Gordon et al, AJHG, AUgust 15, 2019
• Will screening for endometrial cancer soon be routine?  
  Contemorary Ob/Gyn, August 14, 2019
• Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma.  
  Robert Caroline et al. The New England journal of medicine 2019 Aug (7) 626-636
• Genetic Testing Can Reduce Suffering and Save Lives  
  L Corduck, AJMC, August 14, 2019
• Practice Tools  
  NCI, Implementation Science, 2019
• A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients  
  H LaDuca et al, Genetics in Medicine, August 13, 2019
• An Artificial Intelligence Tool to Improve Pancreatic Cancer Outcomes  
  S Rosen, Mato Clinic blog, August 13, 2019
• Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: A Mendelian randomization analysis.  
  Yarmolinsky James et al. PLoS medicine 2019 Aug (8) e1002893
• Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancer  
  S Nissim et al, Nature Genetics, August 12, 2019
• PARP Inhibitors Hit the Pancreatic Cancer Scene  
  D Ternyila, Oncology Nursing News, August 9, 2019
• Artificial intelligence in digital pathology - new tools for diagnosis and precision oncology.  
  Bera Kaustav et al. Nature reviews. Clinical oncology 2019 Aug
• CMS Finalizes Decision to Cover CAR T-Cell Therapy for Medicare Beneficiaries  
  ASCO Post, August 8, 2019